Acupuncture for inflammatory bowel disease: Protocol of a randomized sham‐controlled trial
Brain Behavior and Immunity Integrative · 2026-12 · 16 · 100197
DOI: 10.1016/j.bbii.2026.100197 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Brain Behavior and Immunity Integrative, 2026-12. Verfasst von Behnam Bahadori und 6 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Introduction
Inflammatory bowel disease (IBD) is a debilitating chronic condition that significantly affects quality of life. Current medications for IBD are associated with complications that have led to increased use of complementary therapies in its management.
Methods
This randomized, sham-controlled trial will be conducted among patients with mild-to-moderate IBD recruited from the gastroenterology clinics affiliated with Mashhad University of Medical Sciences.
Participants
(n = 56; 28 per arm) will be randomly allocated, stratified by diagnosis, Crohn's disease (CD) or ulcerative colitis (UC), to receive 16 sessions of acupuncture or sham acupuncture over 8 weeks in addition to their usual medications. The primary outcome is the proportion of participants achieving clinical response at week 8, defined separately using disease-specific instruments: Crohn's Disease Activity Index (CDAI) for CD and Simple Clinical Colitis Activity Index (SCCAI) for UC. Secondary outcomes include changes in disease activity scores, inflammatory biomarkers (fecal calprotectin, C-reactive protein, erythrocyte sedimentation rate), and quality of life (Inflammatory Bowel Disease Questionnaire–32).
Aims
To determine whether adjunctive acupuncture is superior to sham acupuncture in improving disease activity and health-related quality of life in patients with mild-to-moderate IBD.
Conclusion
This trial will provide evidence regarding the efficacy and safety of acupuncture as an adjunctive therapy for mild-to-moderate IBD, and may inform the development of non-pharmacological adjunctive treatment options for IBD.
Trial registration
Iranian Registry of Clinical Trials (IRCT20231009059671N1), registered March 18, 2024 ( https://irct.behdasht.gov.ir/trial/73100)
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Bahadori, B., Bahari, A., Farkhani, E. M., Tehrani, M. V., Shafaei, S., Niazi, M., & Farahmand, S. K. (2026). Acupuncture for inflammatory bowel disease: Protocol of a randomized sham‐controlled trial. Brain Behavior and Immunity Integrative, 16, 100197. https://doi.org/10.1016/j.bbii.2026.100197
Vancouver
Bahadori B, Bahari A, Farkhani EM, Tehrani MV, Shafaei S, Niazi M, et al. Acupuncture for inflammatory bowel disease: Protocol of a randomized sham‐controlled trial. Brain Behavior and Immunity Integrative. 2026;16:100197. doi:10.1016/j.bbii.2026.100197
BibTeX
@article{Bahadori2026,
author = {Bahadori, Behnam and Bahari, Ali and Farkhani, Ehsan Mousa and Tehrani, Malika Vaez and Shafaei, Shirin and Niazi, Mahnaz and Farahmand, Seyyed Kazem},
title = {Acupuncture for inflammatory bowel disease: Protocol of a randomized sham‐controlled trial},
journal = {Brain Behavior and Immunity Integrative},
year = {2026},
volume = {16},
pages = {100197},
doi = {10.1016/j.bbii.2026.100197}
}
EUVIMED